Novavax Balance Sheet Health
Financial Health criteria checks 1/6
Novavax has a total shareholder equity of $-526.4M and total debt of $169.3M, which brings its debt-to-equity ratio to -32.2%. Its total assets and total liabilities are $1.7B and $2.2B respectively.
Key information
-32.2%
Debt to equity ratio
US$169.27m
Debt
Interest coverage ratio | n/a |
Cash | US$909.53m |
Equity | -US$526.44m |
Total liabilities | US$2.24b |
Total assets | US$1.71b |
Recent financial health updates
No updates
Recent updates
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target
Nov 15Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway
Nov 13Novavax, Inc.'s (NASDAQ:NVAX) 35% Dip In Price Shows Sentiment Is Matching Revenues
Nov 01Novavax Q3 Earnings A Week Away - Time To Accept A New Reality
Oct 31Novavax's Future Hinges On Sanofi Deal And Upcoming Milestones
Sep 01Novavax, Inc.'s (NASDAQ:NVAX) Shares Lagging The Industry But So Is The Business
Aug 14Novavax: Staying Long Despite Coming Up Short In Q2
Aug 13Novavax Ahead Of Q2 Earnings - Picking Apart The Sanofi Deal
Jul 26Novavax: New Chapter, Questions Remain
Jun 20Novavax, Inc. (NASDAQ:NVAX) Surges 206% Yet Its Low P/S Is No Reason For Excitement
May 14Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
May 13Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely
May 07Novavax: Another Day Older And Deeper In
Mar 02Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 35% But Its Business Still Trails The Industry
Mar 02Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00
Mar 01Novavax Q4 Earnings Preview: Settlement With Gavi Doesn't Solve Problems
Feb 23Investors Don't See Light At End Of Novavax, Inc.'s (NASDAQ:NVAX) Tunnel
Sep 06Financial Position Analysis
Short Term Liabilities: NVAX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: NVAX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: NVAX has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: NVAX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVAX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if NVAX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.